Literature DB >> 22819212

Regulation of lipid metabolism by p53 - fighting two villains with one sword.

Ido Goldstein1, Varda Rotter.   

Abstract

Both cellular and systemic metabolism of lipids are paramount for homeostasis, and their malfunction leads to devastating pathologies. Recently, exciting findings have linked the p53 tumor suppressor to the regulation of lipid metabolism. Here, we summarize these findings showing a clear role for p53 in enhancing lipid catabolism while inhibiting its anabolism. We also describe the multitude of genes regulated by p53 that participate in or regulate systemic lipid transport. From the compilation of available data a scenario is emerging in which p53 regulates genes involved in lipid metabolism - both in a cancer-preventive effort and, intriguingly, as a means to prevent atherosclerosis. Thus, by regulating lipid metabolism, p53 fights the two major causes of death worldwide - atherosclerosis and cancer.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819212     DOI: 10.1016/j.tem.2012.06.007

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  60 in total

1.  Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.

Authors:  Ge Zhou; Jiping Wang; Mei Zhao; Tong-Xin Xie; Noriaki Tanaka; Daisuke Sano; Ameeta A Patel; Alexandra M Ward; Vlad C Sandulache; Samar A Jasser; Heath D Skinner; Alison Lea Fitzgerald; Abdullah A Osman; Yongkun Wei; Xuefeng Xia; Zhou Songyang; Gordon B Mills; Mien-Chie Hung; Carlos Caulin; Jiyong Liang; Jeffrey N Myers
Journal:  Mol Cell       Date:  2014-05-22       Impact factor: 17.970

Review 2.  The Paradox of p53: What, How, and Why?

Authors:  Yael Aylon; Moshe Oren
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

3.  Reciprocal regulation of acetyl-CoA carboxylase 1 and senescence in human fibroblasts involves oxidant mediated p38 MAPK activation.

Authors:  Inés Marmisolle; Jennyfer Martínez; Jie Liu; Mauricio Mastrogiovanni; María M Fergusson; Ilsa I Rovira; Laura Castro; Andrés Trostchansky; María Moreno; Liu Cao; Toren Finkel; Celia Quijano
Journal:  Arch Biochem Biophys       Date:  2016-10-27       Impact factor: 4.013

Review 4.  p53 in liver pathologies-taking the good with the bad.

Authors:  Meital Charni; Noa Rivlin; Alina Molchadsky; Ronit Aloni-Grinstein; Varda Rotter
Journal:  J Mol Med (Berl)       Date:  2014-11-19       Impact factor: 4.599

Review 5.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

6.  CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress.

Authors:  Baharan Fekry; Kristen A Jeffries; Amin Esmaeilniakooshkghazi; Besim Ogretmen; Sergey A Krupenko; Natalia I Krupenko
Journal:  J Biol Chem       Date:  2016-06-14       Impact factor: 5.157

7.  Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis.

Authors:  Jessie Yanxiang Guo; Gizem Karsli-Uzunbas; Robin Mathew; Seena C Aisner; Jurre J Kamphorst; Anne M Strohecker; Guanghua Chen; Sandy Price; Wenyun Lu; Xin Teng; Eric Snyder; Urmila Santanam; Robert S Dipaola; Tyler Jacks; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

8.  Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells.

Authors:  Huan He; Charles A Conrad; Carol L Nilsson; Yongjie Ji; Tanner M Schaub; Alan G Marshall; Mark R Emmett
Journal:  Anal Chem       Date:  2007-10-12       Impact factor: 6.986

Review 9.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

10.  The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.

Authors:  Che-Pei Kung; Julia I-Ju Leu; Subhasree Basu; Sakina Khaku; Frederick Anokye-Danso; Qin Liu; Donna L George; Rexford S Ahima; Maureen E Murphy
Journal:  Cell Rep       Date:  2016-03-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.